Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biogen Idec
(NQ:
BIIB
)
225.43
-6.56 (-2.83%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biogen Idec
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
43
44
Next >
Medicare Trying To Determine Coverage Of Biogen's Expensive Alzheimer's Drug: NYT
January 03, 2022
Federal officials are struggling with a decision that could determine the future of Biogen Inc's (NASDAQ: BIIB) Alzheimer's drug, Aduhelm, and whether...
Via
Benzinga
Happy New Year - Sunday Edition
January 02, 2022
Starting a new year - we look at tech, pharma and mining stocks and their goings-on.
Via
Talk Markets
4 Top Stock Trades for Friday: Ethereum, NIO, BIIB, BABA
December 30, 2021
Nio, Ethereum, Biogen and Alibaba were our top stock trades for Friday. Let's take a look at how the charts are setting up now.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
December 30, 2021
Gainers Kiora Pharmaceuticals (NASDAQ:KPRX
Via
Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
December 30, 2021
Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) jumped 52.3% to $1.3396. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its Board of Directors. Future...
Via
Benzinga
63 Biggest Movers From Yesterday
December 31, 2021
Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares surged 93.2% to close at $1.70 on Thursday. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its...
Via
Benzinga
What Are Whales Doing With Biogen
December 30, 2021
A whale with a lot of money to spend has taken a noticeably bearish stance on Biogen. Looking at options history for Biogen (NASDAQ:BIIB) we detected 11 strange trades. If we...
Via
Benzinga
Biogen Stock Dives As Samsung Reportedly Denies Rumored $42 Billion Buyout
December 30, 2021
Biogen is under pressure amid troubles for its Alzheimer's and multiple sclerosis meds.
Via
Investor's Business Daily
Biogen Stock Flies As Report Suggests Samsung Group Could Buy It
December 29, 2021
Biogen reportedly approached Samsung Group to negotiate a buyout.
Via
Investor's Business Daily
Expert Ratings For Biogen
December 22, 2021
Within the last quarter, Biogen (NASDAQ:BIIB) has observed the following an...
Via
Benzinga
Analyst Ratings For Biogen
December 21, 2021
Analysts have provided the following ratings for Biogen (NASDAQ:BIIB) withi...
Via
Benzinga
Why Biogen Shares Are Falling Today
December 30, 2021
Biogen Inc (NASDAQ: BIIB) is trading lower Thursday morning after Samsung BioLogics denied that its parent company, Samsung Group, is looking to buy Biogen. Korea Economic Daily...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 30, 2021
Gainers Kiora Pharmaceuticals (NASDAQ:KPRX) stock moved upwards by 20.4% to $1.06 during Thursday's pre-market session. The market value of their outstanding shares is...
Via
Benzinga
The U.S Indices Continue To Break Price Records Despite Year-End Economic Slowdown
December 30, 2021
The US oil inventories dropped nearly 3.6 million barrels. In the background of such data, given the reduction of concerns about the impact of Omicron on demand for petroleum products, the energy...
Via
Talk Markets
20 Stocks Moving in Thursday's Pre-Market Session
December 30, 2021
Gainers BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) rose 33.6% to $3.10 in pre-market trading. BiondVax reported successful closing of $9.8 million follow-on underwritten...
Via
Benzinga
5 Stocks To Watch For Thursday, Dec. 30
December 30, 2021
Five stocks that you should keep in mind today. (Thursday, Dec. 30)
Via
Talk Markets
5 Stocks To Watch For December 30, 2021
December 30, 2021
Some of the stocks that may grab investor focus today are: Four Corners Property Trust, Inc. (NYSE: FCPT) reported acquisition of three Mr. Tire Properties for $2.5 million. The...
Via
Benzinga
Peering Into Biogen Inc's Recent Short Interest
December 29, 2021
Biogen Inc's (NASDAQ:BIIB) short percent of float has risen 16.43% since last its last report. The company recently reported that it has 2.39 million shares sold short, which is 1...
Via
Benzinga
Annovis Bio on Its Positive Results in Alzheimer's and Parkinson's Clinical Trials
December 27, 2021
Image provided by Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of...
Via
Benzinga
5 Beaten Down Biotech Stocks That Could Bounce Big In 2022
December 27, 2021
Biotech stocks remain poised to eke out modest gains for 2021 after the stellar gains of the previous year. COVID-19 drug and vaccine developers experienced volatility throughout...
Via
Benzinga
Here's How Much $100 Invested In Biogen 15 Years Ago Would Be Worth Today
December 27, 2021
Biogen (NASDAQ:BIIB) has outperformed the market over the past 15 years by 3.22% on an annualized basis. Buying $100 In BIIB: 15 years ago, an investor could have purchased 2.20...
Via
Benzinga
Christmas is Coming
December 23, 2021
November saw a very modest increase in consumer spending, 0.6%. That means we are probably making up for it this month.
Via
Talk Markets
BAD ETF: The Top “Sin Stock” Holdings in the New Anti-ESG Fund That Debuts Today
December 22, 2021
There's a new ETF on the block from BAD Investment Company and it seeks to offer investments in sin stocks for interested traders.
Via
InvestorPlace
10 Biggest Price Target Changes For Wednesday
December 22, 2021
Barclays lifted the price target on FactSet Research Systems Inc. (NYSE:
Via
Benzinga
Biogen Slashes Alzheimer's Treatment Price Amid Launch 'Gone Awry'
December 20, 2021
A maintenance dose of the Alzheimer's drug will cost $28,200 per year.
Via
Investor's Business Daily
After Much Criticism, Biogen Slashes Aduhelm Price In Half
December 20, 2021
In a surprise move, Biogen Inc (NASDAQ: BIIB) announced that it would slash the price of its controversial Alzheimer's drug Aduhelm in half from $56,000 to...
Via
Benzinga
10 Biggest Price Target Changes For Monday
December 20, 2021
JP Morgan raised the price target on Public Storage (NYSE:
Via
Benzinga
EMA's Committee Gives Thumbs Down To Biogen's Controversial Alzheimer's Drug, As Expected
December 17, 2021
The European Medicines Agency has recommended the European Commission to reject Biogen Inc's (NASDAQ: BIIB) Aduhelm, an expected blow to its hopes of finding a...
Via
Benzinga
The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx
December 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Merck Announces Publication Of Positive Data From Late-Stage Study Of Oral...
Via
Benzinga
Biogen Outlines Aduhelm's Confirmatory Trial Plans, Data Expected In 2026
December 16, 2021
Biogen Inc (NASDAQ: BIIB) and Eisai Co Ltd (OTC: ESALY) are looking to get initial data from the FDA-mandated confirmatory trial for its Alzheimer’s...
Via
Benzinga
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
43
44
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.